The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The next-generation sequencing ...
NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn screening (NBS) programs have traditionally relied on ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low socioeconomic status, Black race or Hispanic ethnicity, and Medicaid or Medicare ...
Next-generation sequencing (NGS), especially long-read DNA sequencing, is transforming infectious organism detection by providing faster, more detailed insights and enabling more advanced ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results